Journal
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY
Volume 9, Issue -, Pages -Publisher
FRONTIERS MEDIA SA
DOI: 10.3389/fcell.2021.695325
Keywords
glioblastoma; immunotherapy; immune evasion; tumor microenvironment; peptide and mRNA vaccines
Categories
Funding
- Nazarbayev University Faculty-Development Competitive Research Grants Program [280720FD1907]
Ask authors/readers for more resources
The invasive nature of glioblastoma poses challenges to standard care, as conventional therapies have failed to completely eradicate glioblastoma cells. New approaches including small molecule inhibitors, immunotherapy, and virotherapy, focus on boosting the host immune system to interfere with immune evasion of glioblastoma cells, showing promise for therapeutic applications.
According to the invasive nature of glioblastoma, which is the most common form of malignant brain tumor, the standard care by surgery, chemo- and radiotherapy is particularly challenging. The presence of glioblastoma stem cells (GSCs) and the surrounding tumor microenvironment protects glioblastoma from recognition by the immune system. Conventional therapy concepts have failed to completely remove glioblastoma cells, which is one major drawback in clinical management of the disease. The use of small molecule inhibitors, immunomodulators, immunotherapy, including peptide and mRNA vaccines, and virotherapy came into focus for the treatment of glioblastoma. Although novel strategies underline the benefit for anti-tumor effectiveness, serious challenges need to be overcome to successfully manage tumorigenesis, indicating the significance of developing new strategies. Therefore, we provide insights into the application of different medications in combination to boost the host immune system to interfere with immune evasion of glioblastoma cells which are promising prerequisites for therapeutic approaches to treat glioblastoma patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available